In recent years, we have seen a shift toward decentralized and hybrid clinical studies that help bring clinical trials to patients and reduce the burden of study participation. COVID-19 accelerated this shift, increasing emphasis on patient access, safety, and engagement. Now, proactively incorporating community clinicians and sites into clinical research is the next step in broadening the reach and diversity of oncology studies while still generating high-quality data.
In this episode, Premier Research’s Dr. Ashley Herrick, Executive Director, Oncology Strategy; joins us in a conversation about:
- What it means today to bring the trial to the patient
- The benefits of including community sites in oncology clinical trials
- How to select community sites for inclusion in oncology studies